NCT02407106View on ClinicalTrials.gov

Efficacy of BLIS K12 as Preventive Measure for Rheumatic Children

NAUnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

March 31, 2016

Conditions
Rheumatic Fever
Interventions
DIETARY_SUPPLEMENT

Streptococcus Salivarius BLIS K12

Once daily tablet of BLIS K 12 to be slowly dissolved orally every evening.

Sponsors
All Listed Sponsors
lead

Kaplan Medical Center

OTHER